Publication | Closed Access

Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial

Specific Patient SubgroupsPharmacologyCetp InhibitionHyperlipidemiaPharmacotherapyPlasma LipidsMedicineAtherosclerosisDyslipidemia